Clinical Trial Update: A Clinical Study Evaluating Licaminlimab for Dry Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows a study evaluating Licaminlimab for Dry Eye Disease is in Phase 2/Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Licaminlimab (Licaminlimab)

Snippet

Sponsor: Oculis | Conditions: Dry Eye Disease (DED) | Phase 2, Phase 3 | Status: RECRUITING